Cytokinetics, Incorporated
NasdaqGS:CYTK
$ 65.34
$0.00 (0.00%)
$ 65.34
$0.00 (0.00%)
End-of-day quote: 04/27/2024

CYTK - Cytokinetics Stock Prediction 2025 - 2030

20 years of reliable Cytokinetics stock forecast. The Wall Street analysts predict Outperform for CYTK. See at a glance whether NasdaqGS:CYTK will rise in the future.

$0.00
Forecast 2023
$78.14
Forecast 2025
$132.80
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$78.14
Forecast 2030
$132.80
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.68
Price-to-book Ratio
N/A
Market Cap
7.94B
TEV
8.15 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$87.92

Cytokinetics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Cytokinetics Stock Forecast 2023

$94.00

In the last five quarters, Cytokinetics’s Price Target has risen from $65.73 to $87.92 - a 33.76% increase. Eighteen analysts predict that Cytokinetics’s share price will increase in the coming year, reaching $94.00. This would represent an increase of 6.92%.

43.86%
43.86
Last update: 04/27/2024

Highest Price Target $122.00

Average Price Target $94.00

Lowest Price Target $42.40

Cytokinetics Stock Prediction 2025

Cytokinetics Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $70.93. An increase of 8.55% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $71.58. An increase of 9.56% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $72.24. An increase of 10.56% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $72.90. An increase of 11.56% compared to the previous month's estimate.

Cytokinetics Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $73.55. An increase of 12.57% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $74.21. An increase of 13.57% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $74.86. An increase of 14.57% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $75.52. An increase of 15.58% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $76.17. An increase of 16.58% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $76.83. An increase of 17.58% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $77.48. An increase of 18.58% compared to the previous month's estimate.

Cytokinetics Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $78.14. An increase of 19.59% compared to the previous month's estimate.

Cytokinetics Stock Forecast 2030

Stock Forecast for the Price of an Cytokinetics Share in Jan 2030.

In January 2030, analysts believe the stock price will be $120.55. An increase of 84.49% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Feb 2030.

In February 2030, analysts believe the stock price will be $121.66. An increase of 86.2% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Mar 2030.

In March 2030, analysts believe the stock price will be $122.77. An increase of 87.9% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Apr 2030.

In April 2030, analysts believe the stock price will be $123.89. An increase of 89.61% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in May 2030.

In May 2030, analysts believe the stock price will be $125.00. An increase of 91.31% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Jun 2030.

In June 2030, analysts believe the stock price will be $126.12. An increase of 93.01% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Jul 2030.

In July 2030, analysts believe the stock price will be $127.23. An increase of 94.72% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Aug 2030.

In August 2030, analysts believe the stock price will be $128.34. An increase of 96.42% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Sep 2030.

In September 2030, analysts believe the stock price will be $129.46. An increase of 98.13% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Oct 2030.

In October 2030, analysts believe the stock price will be $130.57. An increase of 99.83% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Nov 2030.

In November 2030, analysts believe the stock price will be $131.68. An increase of 101.54% compared to the previous month's estimate.

Stock Forecast for the Price of an Cytokinetics Share in Dec 2030.

In December 2030, analysts believe the stock price will be $132.80. An increase of 103.24% compared to the previous month's estimate.

P/E
0.00
Beta
0.68
Price-to-book Ratio
N/A
Market Cap
7.94B
TEV
8.15 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$87.92

Cytokinetics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Cytokinetics, Incorporated?

The following analysts have recently covered Cytokinetics:

Barclays
Cantor Fitzgerald & Co.
Goldman Sachs
H.C. Wainwright & Co.
Jefferies LLC
JMP Securities
Mizuho Securities USA LLC
Morgan Stanley
Needham & Company
Oppenheimer & Co. Inc.
Piper Sandler Companies
Raymond James & Associates
Marktfeld
J.P. Morgan
UBS Investment Bank
B. Riley Securities, Inc.
Equisights
Leerink Partners LLC
Truist Securities
Baptista Research
Foveal LLP
CGS International
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Cytokinetics, Incorporated?

The following sell-side analysts have recently covered Cytokinetics:

Gould, Carter Lewis
Duncan, Charles Cliff
Pantginis, Joseph
Tewari, Akash
Butler, Jason Nicholas
Syed, Salim Qader
Hung, Jeff
Belanger, Serge D.
Rahimi, Yasmeen
Paraskevopoulos, Michail
Romero, Tessa Thomas
Verma, Ashwani
Mamtani, Mayank
McCutcheon, Sean
Talsania, Parth
Choi, Paul
Ruiz, Roanna Clarissa H.
Devarakonda, Srikripa
Majumdar, Ishan
Gershell, Leland James
Roy, Amit
(This information refers to the last 90 days.)